Device Cardiopulmonary

Mc3 Nautilus(Tm) Ecmo Oxygenator

Payments companies reported to CMS as associated with Mc3 Nautilus(Tm) Ecmo Oxygenator. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$920Kassociated payments (2023-2025)
270clinicians with associated payments
1company reporting

By year

2023 $34K
2024 $865K
2025 $21K

Payments reported as associated with Mc3 Nautilus(Tm) Ecmo Oxygenator, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Surgery $824K
Thoracic Surgery (Cardiothoracic Vascular Surgery) $27K
Emergency Medicine $12K
Anesthesiology $10K
Critical Care Medicine (Internal Medicine) $7,856
Pulmonary Disease $5,086

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Mc3 Nautilus(Tm) Ecmo Oxygenator

These are the largest totals companies reported as associated with Mc3 Nautilus(Tm) Ecmo Oxygenator. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Robert Bartlett Ann Arbor, MI Surgery $819,327.47
Colin Mccloskey Chicago, IL Emergency Medicine $9,489.44
Jeffrey Dellavolpe Fort Sam Houston, TX Critical Care Medicine (Internal Medicine) $3,712.87
Tyler Wahl Vestavia, AL Thoracic Surgery (Cardiothoracic Vascular Surgery) $3,390.55
Rafal Kopanczyk Columbus, OH Anesthesiology $3,373.78
Javier Castillo-Granero Bayamon, PR Thoracic Surgery (Cardiothoracic Vascular Surgery) $2,955.94
Steven Debeer Plantation, FL Thoracic Surgery (Cardiothoracic Vascular Surgery) $2,266.97
Elizabeth Karkoski-Gardner Seattle, WA Nurse Practitioner $1,675.48
Britton Blough Durham, NC Pulmonary Disease $1,626.51
Martha Mcbride Birmingham, AL Neonatal (Nurse Practitioner) $1,588.22

Prescribed Mc3 Nautilus(Tm) Ecmo Oxygenator?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.